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Background
Cardiovascular magnetic resonance (CMR) imaging is the
gold standard imaging modality for characterization of
dilated cardiomyopathy (DCM). We recently identified
genetic variants that truncate the giant protein Titin
(TTN) accounting for up to 25% of DCM cases: a discov-
ery that will increase the utility of genetic testing and
family screening in DCM. However, the clinical conse-
quences of TTN truncating variants (TTNtv) are
unknown. Here, we integrated the power of CMR and
capacity of next generation sequencing (NGS) to assess
the relationship between genotype and phenotype in a
non-ischemic DCM population.
Methods
319 patients referred for characterization of DCM were
recruited and underwent quantitative CMR study with
detailed phenotyping (Siemens Avanto or Siemens Sonata
1.5T scanners). Additional clinical data were collected.
TTN genotypes were determined by target enrichment
using SureSelect and NGS sequencing using the SOLiD
5500 platform.
Results
TTN truncating variants (TTNtv) were identified in 13%
(n = 42) of cases, the commonest genetic cause of
DCM. Table 1 compares the CMR and clinical charac-
teristics of TTNtv-positive and TTNtv-negative cohorts.
TTNtv-positive DCM patients had lower left ventricular
(LV) ejection fraction (EF) (p = 0.02), thinner LV walls
(p < 0.02) and higher incidence of sustained ventricular
tachycardia (VT) (p = 0.001) which was independent of
EF. No statistically significant difference in the prevalence
of midwall fibrosis existed between the two groups.
Multivariate linear regression models that considered age,
sex, TTNtv presence and position (distance from the
protein N-terminus) indicated that TTNtv position was
significantly correlated with biventricular ejection fraction
and indexed stroke volumes such that more distal trunca-
tions had worse indices of cardiac function. For example, a
C-terminal TTNtv would be associated with an absolute
reduction in LV EF of 18 ± 7%, (p = 0.005), as compared
with an N-terminal TTNtv.
Conclusions
These data highlight the prevalence of TTNtv in this
unselected DCM cohort and suggest that TTNtv-
positive DCM patients may benefit from tailored clinical
management. Sustained VT, LV wall thickness and
LVEF influence DCM outcomes. The increased risk of
sustained VT in TTNtv-positive DCM may warrant a
lower threshold for device therapy, as recommended for
DCM caused by LMNA mutations. As distal TTNtv
were associated with worse LV function, more aggres-
sive clinical management may be appropriate in patients
carrying these variants. The phenotypic expression of
genetic substrates can be highly variable, and CMR is
central to the accurate phenotypic description of this
common yet heterogenous condition. Enhanced molecu-
lar understanding may lead to strategies to alter disease
course beyond current pharmacological and device
based therapy.
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LV EDVi (mL/m2) 136 ± 38 140 ± 34.5 0.34
LV ESVi (mL/m2) 87.5 ± 39.1 96.5 ± 36.7 0.07
LV SVi (mL/m2) 48.2 ± 12.9 43.4 ± 13.6 0.03*
LV EF (%) 37.5 ± 12.2 32.7 ± 13 0.02*
RV EDVi (mL/m2) 89.4 ± 24.7 90.7 ± 25.5 0.71
RV ESVi (mL/m2) 45.2 ± 22.3 50.6 ± 24.9 0.15
RV SVi (mL/m2) 44.4 ± 12.6 40.1 ± 15.6 0.09
RV EF (%) 51.6 ± 14.1 45.5 ± 15.5 0.04*
LAVi (mL/m2) 63.8 ± 26.8 66.7 ± 25.7 0.30
LVMi (g/m2) 95.4 ± 27.6 85.5 ± 18.6 0.03*
Lateral WTi (mm/m2) 3.1 ± 0.7 2.8 ± 0.7 0.002**
Septal WTi (mm/m2) 4.2 ± 0.9 3.9 ± 0.8 0.02*
Maximum WTi (mm/m2) 5.3 ± 1.0 4.9 ± 0.9 0.01*
Mid-wall fibrosis present 94/270 13/42 0.73
Clinical data
Age at Diagnosis (years) 53.4 ± 13.3 50.4 ± 13.9 0.29
NYHA status 1/2/3/4 116/103/36/1 19/16/4/1 0.43
Sustained VT 20/97 9/14 0.001**
Conduction Disease 82/227 9/37 0.19
Family history of DCM 24/218 10/38 0.018*
Values are means ± SD for continuous data. TTN, Titin; LV, left ventricular; RV, right ventricular; EDVi/ESVi, end diastolic/systolic volume indexed to body surface
area (BSA); SVi, stoke volume indexed to BSA; EF, ejection fraction; LAVi, left atrial volume indexed to BSA; LVMi, LV mass indexed to BSA; WTi, wall thickness
indexed to BSA; VT, ventricular tachycardia; NYHA, New York Heart association functional class. *p < 0.05, **p < 0.01
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